Abstract: Preparations of glycoproteins, e.g., therapeutic preparations of glycoproteins, having altered levels of affinity for Fc? receptors relative to reference glycoprotein preparations, and methods of making and methods of using such preparations, are described.
Type:
Application
Filed:
September 25, 2013
Publication date:
September 10, 2015
Applicant:
Momenta Pharmaceuticals, Inc.
Inventors:
Nathaniel J. Washburn, Jonathan C. Lansing, Carlos J. Bosques, Naveen Bhatnagar, Dorota A. Bulik, Lynn Markowitz, Sandra Sipsey
Abstract: Among other things, the present disclosure provides methods for enriching, identifying, and/or quantifying unusually modified glycans (e.g., phosphorylated glycans, sulfated glycans, and/or multi-acetylated glycans). In many embodiments, methods comprise providing a glycan preparation from which sialic acids have been released; subjecting the sialidase-treated glycan preparation to a separation technique that separates glycans based on charge-to-mass ratio; and quantifying the charged products using at least one quantification standard.
Type:
Grant
Filed:
December 18, 2009
Date of Patent:
August 11, 2015
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Carlos J. Bosques, Jennifer Lynn Murphy, Sibel Nur Gunay, Zachary Shriver, Cuihua Liu
Abstract: Glatiramer acetate containing compositions and drug products can be manufactured using methods that include a step of measuring one or both of the alpha helical content of the glatiramer acetate and the random coil content of the glatiramer acetate. These measurements can be compared to particular values or ranges for one or both of alpha helical and random coil content. The results of the comparison can be used in determining whether a given batch of glatiramer acetate should be used to manufacture a glatiramer acetate-containing drug product. The measurement of alpha helical content of the glatiramer acetate and the random coil content can be carried out using various methods, including circular dichroism.
Abstract: Methods for analyzing, selecting, characterizing or classifying compositions of a co-polymer, e.g., glatiramer acetate are described. The methods entail analysis of pyro-glutamate in the composition, and, in some methods, comparing the amount of pyro-glutamate present in a composition to a reference standard.
Type:
Grant
Filed:
September 5, 2013
Date of Patent:
July 21, 2015
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Xianping Zhu, Zachary Shriver, Yanjie Jiang, Corinne Bauer, James Eric Anderson, Peter James Ahern
Abstract: Methods of evaluating heparin preparations, e.g., for suitability for use as a drug or for use in making a drug, by determining the absence, presence or amount of a structural signature, wherein, e.g., the structural signature is indicative of the methods used to make the heparin preparation.
Type:
Grant
Filed:
February 21, 2012
Date of Patent:
June 30, 2015
Assignee:
MOMENTA PHARMACEUTICALS, INC.
Inventors:
Nur Sibel Gunay, Miroslaw Lech, Sucharita Roy, John Schaeck, Jennifer Ozug, Daniela Beccati, Ishan Capila
Abstract: The present disclosure provides methods for analyzing structure and/or composition of N-glycans. Such methods often involve digestion of N-glycans with multiple exoglycosidases. In some embodiments, N-glycans are digested with multiple exoglycosidases simultaneously. In some embodiments, N-glycans are digested with multiple exoglycosidases sequentially. In some embodiments, methods in accordance with the present disclosure involve comparison of cleavage products of N-glycans that have been digested with multiple exoglycosidases simultaneously to N-glycans that have been digested with multiple exoglycosidases sequentially.
Type:
Grant
Filed:
December 19, 2012
Date of Patent:
May 12, 2015
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Ian Christopher Parsons, Dorota A. Bulik, Carlos J. Bosques, Lakshmanan Thiruneelakantapillai, Brian Edward Collins
Abstract: The presently disclosed subject matter provides methods for evaluating and characterizing peptides, peptide mixtures, and polypeptide mixtures. More particularly, the presently disclosed subject matter provides methods for evaluating or characterizing complex peptide or polypeptide mixtures comprising glutamic acid, alanine, tyrosine, and lysine, e.g., Copolymer-1 or glatiramer acetate, including, but not limited to, methods of identifying, isolating, quantifying, and purifying amino acids, peptides, polypeptides, and combinations thereof having a diethylamide group instead of a carboxyl group present on the C-terminus. The presently disclosed methods can be used to determine the mole percent of polypeptides having a diethylamide group at a C-terminus thereof and can be used to evaluate one or more properties of a sample of one polypeptide mixture as compared to one or more properties of a different sample of a polypeptide mixture.
Type:
Grant
Filed:
September 6, 2013
Date of Patent:
January 6, 2015
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Zachary Shriver, Ganesh V. Kaundinya, Jonathan C. Lansing, Corinne Bauer, Xiangping Zhu
Abstract: The presently disclosed subject matter provides methods for evaluating and characterizing peptides, peptide mixtures, and polypeptide mixtures. More particularly, the presently disclosed subject matter provides methods for evaluating or characterizing complex peptide or polypeptide mixtures comprising glutamic acid, alanine, tyrosine, and lysine, e.g., Copolymer-1 or glatiramer acetate, including, but not limited to, methods of identifying, isolating, quantifying, and purifying amino acids, peptides, polypeptides, and combinations thereof having a diethylamide group instead of a carboxyl group present on the C-terminus. The presently disclosed methods can be used to determine the mole percent of polypeptides having a diethylamide group at a C-terminus thereof and can be used to evaluate one or more properties of a sample of one polypeptide mixture as compared to one or more properties of a different sample of a polypeptide mixture.
Type:
Grant
Filed:
June 24, 2013
Date of Patent:
December 30, 2014
Assignee:
Momenta Pharmaceuticals, Inc.
Inventors:
Zachary Shriver, Ganesh V. Kaundinya, Jonathan C. Lansing, Corinne Bauer, Xiangping Zhu
Abstract: Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using copper, are described.
Abstract: Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using ammonium and/or lysine, are described.
Type:
Application
Filed:
March 14, 2013
Publication date:
September 18, 2014
Applicant:
MOMENTA PHARMACEUTICALS, INC.
Inventors:
Brian Edward Collins, Holly Prentice, Brett Belongia, Rasheed Tijani
Abstract: Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using putrescine, are described.